| abstract |
The present invention relates to a heterocyclic compound consisting of a core nitrogen atom surrounded by three side chain groups, wherein two of the three side chain groups are preferably benzimidazolyl methyl and tetrahydroquinolyl, and the third side chain group N and, optionally, further rings). The compound binds to chemokine receptors, including CXCR4 and CCR5, and has the effect of protecting target cells from being infected by human immunodeficiency virus (HIV). |